V 2.5 FIRM EXT
Report
- Report Number
- 0002954917-2013-00075
- Event Type
- Injury
- Date Received
- May 29, 2013
- Date of Event
- February 1, 2013
- Report Date
- May 15, 2013
- Manufacturer
- CONCENTRIC MEDICAL
- Product Code
- NRY
- PMA / PMN Number
- K090085
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
Narratives
SUBJECT DEVICE IS NOT AVAILABLE.
THE SUBJECT DEVICE IS NOT AVAILABLE; THEREFORE, ANALYSIS CANNOT BE PERFORMED. FROM THE INFORMATION AVAILABLE, THERE IS NO INDICATION THAT THE REPORTED EVENT IS RELATED TO PRODUCT SPECIFICATIONS NONCONFORMANCE OR MISUSE. THERE IS ALSO NO INDICATION THAT THE SUBJECT DEVICE MALFUNCTIONED. HOWEVER, HEMORRHAGE IS A KNOWN RISK ASSOCIATED WITH ENDOVASCULAR PROCEDURES AND IS NOTED AS SUCH IN THE DIRECTIONS FOR USE (DFU). THEREFORE, A ROOT CAUSE OF ANTICIPATED PROCEDURAL COMPLICATIONS HAS BEEN ASSIGNED TO THIS EVENT.
DURING A THROMBECTOMY PROCEDURE TWO RETRIEVERS WERE USED IN THE OCCLUDED LEFT INTERNAL CAROTID ARTERY (L-ICA). IT WAS REPORTED THAT A SUBARACHNOID HEMORRHAGE (SAH) OCCURRED "AT THE ROUTE WHERE RETRIEVERS WAS INSERTED". THE PATIENT DIED THREE DAYS POST PROCEDURE. THE PHYSICIAN STATED THAT THE PATIENT¿S DEATH WAS RELATED TO THE PROGRESS OF THE PRESENTING CEREBRAL INFARCTION AND NOT TO THE SAH. NO ADDITIONAL INFORMATION IS AVAILABLE.
DURING A THROMBECTOMY PROCEDURE, TWO RETRIEVERS WERE USED IN THE OCCLUDED LEFT INTERNAL CAROTID ARTERY (L-ICA). IT WAS REPORTED THAT A SUBARACHNOID HEMORRHAGE (SAH) OCCURRED "AT THE ROUTE WHERE RETRIEVERS WAS INSERTED". THE PATIENT DIED THREE DAYS POST PROCEDURE. THE PHYSICIAN STATED THAT THE PATIENT¿S DEATH WAS RELATED TO THE PROGRESS OF THE PRESENTING CEREBRAL INFARCTION AND NOT TO THE SAH. NO ADDITIONAL INFORMATION IS AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 236420 | V 2.5 FIRM EXT | CATHETER, THROMBUS RETRIEVER | NRY | CONCENTRIC MEDICAL | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 66 YR | Other | V 2.0 FIRM EXT PEBAX (CONCENTRIC) |